New expensive treatments for hepatitis C infection: have US payers reached a tipping point?
Live broadcast: September 24, 2014 at 10AM EDT
The launch of Sovaldi® (sofosbuvir, Gilead) in the US earlier this year marked an important advance in the treatment of hepatitis C virus (HCV) infection, but its price –at $84,000 for a 12-week treatment course – has come under heavy scrutiny. Although downstream cost savings mean that Sovaldi® represents good value to payers over the long term, the product finds itself at the center of a growing debate about the future of drug pricing and cost containment in a health system struggling to cope with the escalating costs of specialty medications.
In this webinar, we ask if recent experience with HCV treatments would suggest payers have reached a tipping point in terms of their willingness or ability to accept high-priced, specialty drugs. We will examine the key dynamics in the HCV market, actions already taken by US payers to contain HCV treatment costs, what further strategies could be considered (taking the practicalities of the US system into account), and future implications for high-cost treatments.
Register Free at http://www.pharmexec.com/expensive
Engineer Your Business to Win in the Mobile Selling Moment
Live broadcast: September 25, 2014 at noon EDT
Mobile moments -- the expectation I can get what I want, anytime, in my immediate context -- is the new battleground for engaging employees and healthcare providers. If you're not there to provide an instant answer, you’ll lose.
Join guest speaker Ted Schadler of Forrester Research, Inc. as he outlines how to engineer your business to win the mobile moment. Also learn how Stryker Medical leapt ahead of the competition with mobile selling moments for their sales reps.
Register Free at http://www.pharmexec.com/mobileselling
Establishing Processes and Controls to Ensure an Inspection-ready TMF Every Day
Live broadcast: October 1, 2014 at 2pm EDT
The MHRA recently updated its definition of a critical GCP finding to include TMFs that are not readily accessible or incomplete. It is difficult to achieve the right level of control and accessibility without the proper technology. Join PharmaStart’s Rebecca Moraris and Veeva’s Mike Burton to hear how PharmaStart implemented Veeva Vault eTMF to automate critical processes and provide their partners remote access to the TMF.
Register Free at http://www.pharmexec.com/inspection
ON-DEMAND WEBCASTS NOW AVAILABLE FOR REPLAY
Are Your Patient Access Solutions Performing up to Your Expectations? Leveraging data and analytics to enhance performance
Recorded: August 6, 2014
Patient Access solutions must be supported by rich sources of evidence, demonstrations of convincing payback, and sophisticated predictive models. But how can you tell if your campaign is performing up to expectations? And if it isn’t, do you have a strategy for mid-course correction?
Paul LeVine and Robert Leedom leverage their deep-seated experience in the analytics that drive patient access to show you that you can identify and improve the performance of your patient access solutions through effective mid-course corrections.
Register Free at http://www.pharmexec.com/patientaccess
Seeing the Whole Picture: Harnessing the Power of Data to Drive Smarter Marketing Decisions
Recorded: August 7, 2014
Learn how big data is revolutionizing how organizations measure the true impact of their digital marketing efforts. Join leading experts in digital marketing and analytics as they share real-world insights on how new methods of data capture and integration are breaking down current barriers to individual channel analysis and giving marketers the ability to drive real performance improvements.
Register Free at http://www.pharmexec.com/picture
Leveraging Analytics to Inform Payer Messaging: 3 Case Studies
Recorded: June 18, 2014
Market access is a key challenge for Specialty drugs today. Join Cardinal Health Specialty Solution’s Chief Medical Officer, Dr. Bruce Feinberg, on June 18th at 2:00 PM EST for a provocative discussion of the importance of high-value analytics using real world data to create impactful market messages and ensure brand success.
Register Free at http://www.pharmexec.com/payermessaging
Top 10 Clinical Trial Cost-Cutting Innovations
Recorded: June 26, 2014
Clinical research experts continue to observe the rising costs and reduced efficiency of clinical studies. At the same time, today’s evolving healthcare landscape prioritizes empowering the patient. This combination has resulted in clinical research shifting towards a patient-centric model. Understanding these changes and implementing appropriate strategies is vital to improving outcomes.
Join the discussion as Ms. Erem Latif, Trial Enhancement Services, UBC, will share proven innovative and cost-cutting strategies to maximize the efficiency and effectiveness of clinical research.
Register Free at http://www.pharmexec.com/top10
UBC Express Scripts
Methods for patient-centered endpoint selection in rare disease drug development programs
Recorded: July 23, 2014
While stakeholder groups have called for patient engagement in rare disease drug development programs, traditional methods for engaging patients in endpoint strategy are very often impossible due to the nature of rare diseases. This webinar will review innovative methods for gathering patient input to inform endpoint selection and provide specific examples of successful solutions.
Register Free at http://www.pharmexec.com/endpoint
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Recorded: May 14, 2014 from 11-noon Eastern
Attend this webcast to discover how innovations in digital medicine and electronic data capture enable accurate and timely insight into medication adherence during a clinical trial – helping to determine optimum dosing ranges and reducing clinical trial attrition, especially in Phase III trials.
Register Free at http://www.pharmexec.com/pinpoint
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Recorded on: March 19, 2014
Challenged by the need to gather real-world evidence to meet post-marketing payer and regulatory evidence requirements?
Dr. Janine Collins, Senior Director, European Risk Management, and Krista Payne, Executive Director, Sr. Research Scientist, Value Demonstration, will share current perspectives, opportunities, and challenges in relation to the impact of converging payer and regulator evidence requirements on PASS and PMR studies.
Register Free at http://www.pharmexec.com/evidence
UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Recorded on: March 5, 2014
A must attend webinar for life sciences companies who are serious about driving a successful multichannel strategy by overcoming their promotional content challenges through a smarter end-to-end content management approach. Hear from our experts, Jan van den Burg, VP Commercial Strategy at Veeva Systems and Chris Moore, Partner at Ernst & Young and Life Sciences Content Management & Analytics Expert. Learn about the key factors for successful execution and the benefits you stand to gain, including enhanced marketing and brand cooperation, better scaling of content both globally and locally, remaining compliant across channels, all whilst lowering costs.
Register Free at http://www.pharmexec.com/multichannel
New Industry Research: Transforming Clinical R&D Strategy and Performance with Real-World Data
Recorded on: February 13, 2014
Join speakers from the Tufts Center for the Study of Drug Development, Oracle Health Sciences, and Context Matters to explore how protocol and trial designs can be optimized not only for greater R&D efficiency but also to discover health economic outcomes with clinical outcomes.
Register Free at http://www.pharmexec.com/performance
Evaluation of EU Post-Authorization Safety Studies Using Recent EU-RMP Summary Data: Analysis, Trends, Implications
Recorded on: January 29, 2014
This Webcast will provide an overview of recent trends in EU PASS, including an analysis of a sample of EU-RMP summary data, description of PASS types requested and comparison/contrast of characteristics between drug types.
Implications for Pharmaceutical Companies and lessons learnt will be discussed
Register Free at http://www.pharmexec.com/eu_rmp
Pre-Approval Risk Mitigation Strategies and Proactive Safety Considerations
Recorded on: December 10, 2013
Discover ways biopharmaceutical companies can proactively prepare during drug development to monitor and assess patient safety in the postapproval period.
Register Free at http://www.pharmexec.com/preapproval
UBC Express Scripts
An Intro to Utility Assessment Methods
Recorded on: December 5, 2013
This webinar will provide an introduction to utility theory and utility assessment methods with select case studies, in addition to a discussion of the influence of the National Institute of Clinical Excellence (NICE) on utility assessment. We will focus on direct utility assessment, indirect utility assessment (multi-attribute measures and condition – specific measures), deriving utilities from condition-specific measures, and mapping methods.
Register Free at http://www.pharmexec.com/utility
Avoid the Last Minute Rush-Planning Ahead for Successful Global Market Access
Recorded on: November 20, 2013
Successful market access is never easy, but waiting too long to plan for it can make life harder than it need be. In our experience, while there are companies that plan well, too few do this at the right time in the product development lifecycle. There are always difficult questions to be addressed and a range of uncertainties that must be considered in approaching global market access and the associated evidence generation activities. In this webcast, we:
- Highlight some of the common pitfalls to avoid
- Outline a process that will ensure key questions are addressed (but won’t guarantee commercial success!)
- Provide case studies to illustrate sensible planning for evidence generation activities
Register Free at http://www.pharmexec.com/rush
Oncology Data Management Innovations
Recorded on: November 20, 2013
Join us for a webinar highlighting innovations in data and information management specifically for Oncology. Oncology commercial teams today continue to face several important issues, including data gaps due to specialty distribution, small patient counts at local levels, integrating data across infusion and pharmacy channels, understanding product usage across multiple indications, and more.
Register Free at http://www.pharmexec.com/datamgmt
Let the Sunshine In: What Executives Need to Know as the Open Payments Program is Fully Implemented
Recorded on: November 14, 2013
Life Sciences companies must constantly identify and monitor the corporate, reputational, and personal liability risks inherent in their worldwide business activities. The Open Payments program has placed a renewed focus on the relationship between the Life Sciences industry and the healthcare provider community. While the intent of the law is to provide direct insight and transparency into these relationships, the data will ultimately serve as a tool to identify non-compliance by regulators, business intelligence by competitors and potentially controversial analyses by the media - ultimately exposing the company to greater risk across the board. The time to act is now—companies ahead of the pack are considering the various types of scenarios that could potentially increase corporate and executive risks and they are taking action.
Register Free at http://www.pharmexec.com/openpayments
Huron Life Sciences
Pharma's Shift to Custom Solutions Marketing
Recorded on: October 31, 2013
eHealthcare Solutions, experts in digital healthcare marketing with vast experience in building programs that drive results, shares insights about the latest options in custom digital programs targeting physicians/HCPs.
Hear these innovators provide tips on:
- Invigorating your marketing campaigns
- Engaging highly valuable audiences at the right time
- Achieving Maximum Brand Impact and measurable ROI
Register Free at http://www.pharmexec.com/custom
Integrated Strategies for Oncology Provider Engagement
Recorded on: October 30, 2013
During this presentation, we will examine how industry trends are impacting the way Pharmaceutical and Biotech companies interact with physicians, and how to implement strategies to optimize engagement with providers. Specifically, we will discuss:
• Key industry trends impacting oncology providers
• How to implement strategies that foster strong relationships with providers
• New approaches to deliver relevant and timely information to providers
Register Free at http://www.pharmexec.com/provider_engagement
Improving Clinical Trial Management with cloud-based eTMF
Join industry thought leaders, Rik van Mol of Veeva Systems and Eldin Rammell as they share valuable insights on how you can improve your clinical operations efficiency to significantly improve your clinical trial management process. Leading functional CRO, International Drug Development Institute (IDDI), will share their thoughts on how a cloud-based eTMF solution is helping improve their quality and document management processes and enhancing audit management.
Register Free at www.pharmexec.com/etmf
Rare diseases: Evidence, Value, Insight
Recorded on: October 2, 2013 / 10:00am - 11:00am EDT
The past decade has seen numerous innovations in novel therapies for rare diseases, providing clinical and humanistic benefits for populations that are small but have large unmet need. Payers and manufacturers alike recognize the high price of innovation, and healthcare systems have struggled in recent years to manage the budget impact of life-changing treatments for patients with rare diseases
Register Free at www.pharmexec.com/raredisease